ArticleFuture oncology (London, England)2022

Plain language summary of results from the JAVELIN Bladder 100 study: avelumab maintenance treatment for advanced urothelial cancer.

Thomas Powles et al.PubMed ↗Publisher ↗

No numbers read from the abstract.